One of the great concerns when treating high cholesterol lowering drug was that these drugs caused premature dementia or a generalized reduction of congnition (memory function). A new study in 1000 people in Australia reported here:
Australian investigators followed more than 1000 older adults over a 6-year period, assessing memory and global cognition at 2-year intervals. They used MRI to evaluate total brain volume, as well as the volumes of the hippocampus and parahippocampus.
They found no difference in the rate of decline in memory or global cognition between statin users and nonusers, nor did they find differences in brain volume changes.
This is important because it addresses concerns about the safety of Statin Drug from various sources.
Source of Data: Medscape Medical News